Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isophane insulin adverse reaction |
Causative agent |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Porcine isophane insulin (substance) |
Is a |
True |
Isophane insulin |
Inferred relationship |
Some |
|
isophaninsulin NPH |
Is a |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Allergy to isophane insulin |
Causative agent |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Bovine isophane insulin (substance) |
Is a |
True |
Isophane insulin |
Inferred relationship |
Some |
|
Human isophane insulin (substance) |
Is a |
True |
Isophane insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, suspension, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, suspension i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
insulin isofan NPH |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
porcint insulin isofan 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 40/60 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 50/50 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning i fyldt pen a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 25/75 100 enheder/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
porcint insulin isofan 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk porcint insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk porcint insulin isofan 30/70 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing porcine isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing human isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing bovine isophane insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk porcint insulin isofan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 20/80 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 10/90 100 enheder/ml injektionsvæske, cylinderampul a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
humant insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bovint insulin isofan 100 enheder/ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bovin isofaninsulin 100 enheder/ml injektionsvæske, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
bifasisk humant insulin isofan 15/85 100 enheder/ml injektionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Allergy to isophane insulin |
Causative agent |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Human isophane insulin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Bovine isophane insulin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Porcine isophane insulin (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Isophane insulin |
Inferred relationship |
Some |
|
Product containing isophane insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Isophane insulin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Isophane insulin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing only isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing only isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing only isophane insulin and recombinant human regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |
Product containing only isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |
Product containing isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
1 |
Product containing isophane insulin and recombinant human regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |
Product containing isophane insulin and recombinant human regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isophane insulin |
Inferred relationship |
Some |
2 |